References
- Antinori, A., Coenen, T., Costagiola, C., Dedes, N., Ellefson, M., Gatell, J., Girardi, E., Johnson, M., Kirk, O., Lundgren, J., Mocroft, A., Monforte, A. D. A., Phillips, A., Raben, D., Rockstroh, J., & Sabin, C. (2010). Late presentation of HIV infection: A consensus definition. HIV Medicine, 12(1), 61–64. https://doi.org/https://doi.org/10.1111/j.1468-1293.2010.00857.x
- Bickel, M., Hoffmann, C., Wolf, E., Baumgarten, A., Wyen, C., Christoph, D., Spinner, J., Postel, H., Esser, N., Mueller, S., Stoehr, M., Preis, A., Klauke, S., & Schewe, S., & K, C. (2020). High Effectiveness of Recommended first-line antiretroviral Therapies in Germany: A nationwide, Prospective cohort study. Infection, 48(3), 453–461. https://doi.org/https://doi.org/10.1007/s15010-020-01428-1
- Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., Godbole, S. V., Chariyalertsak, S., Santos, B. R., Mayer, K. H., Hoffman, I. F., Eshleman, S. H., Piwowar-Manning, E., Cottle, L., Zhang, X. C., … Fleming, T. R. (2016). Antiretroviral therapy for the Prevention of HIV-1 transmission. New England Journal of Medicine, 375(9), 830–839. https://doi.org/https://doi.org/10.1056/NEJMoa1600693
- Häder, M. (2006). Empirische Sozialforschung: Eine Einführung. Springer Fachmedien Wiesbaden.
- Hendriksen, M., Geers, G., Moons, K., & Groot, J. D. (2013). Diagnostic and prognostic prediction models. Journal of Thrombosis and Haemostasis, 11, 129–141. https://doi.org/https://doi.org/10.1111/jth.12262
- The Joint United Nations Programme on HIV/AIDS (UNAIDS). (2014). 90-90-90 An ambitious treatment target to help end the AIDS epidemic. Retrieved 30.04.2020 from https://www.unaids.org/en/resources/documents/2017/90-90-90
- Kittner, J., Bialy, L. V., Wiltink, J., Thomaidis, T., Gospodinov, B., Rieke, A., Katz, F., Discher, T., Rath, K., Claus, B., Held, G., Friese, G., Schappert, B., Schuchmann, M., & Galle, P. (2015). Lack of awareness in both patients and physicians contributes to a high rate of late presentation in a South West German HIV patient cohort. Infection, 43(3), 299–305. https://doi.org/https://doi.org/10.1007/s15010-014-0719-9
- Mocroft, A., Lundgren, J., Antinori, A., Monforte, A. D. A., Brännström, J., Bonnet, F., Brockmeyer, N., Casabona, J., Castagna, A., Costagliola, D., Wit, S. D., & Fätkenheuer, G. (2015). Late presentation for HIV care across Europe: Update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013. Eurosurveillance, 20(47), 7–18. https://doi.org/https://doi.org/10.2807/1560-7917.ES.2015.20.47.30070
- Peduzzi, P., Concato, J., Kemper, E., Holford, T., & Feinstein, A. (1996). A simulation study of the number of events per variable in logistic regression analysis. Journal of Clinical Epidemiology, 49(12), 1373–1379. https://doi.org/https://doi.org/10.1016/S0895-4356(96)00236-3
- Robert Koch-Institut. (2020). Epidemiologisches Bulletin Nr. 48.
- Rodger, A., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., Lunzen, J. V., Corbelli, G., Estrada, V., Geretti, A., Beloukas, A., Asboe, D., Viciana, P., & Gutiérrez, F. (2016). Sexual Activity without Condoms and risk of HIV transmission in Serodifferent Couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA, 316(2), 171–181. https://doi.org/https://doi.org/10.1001/jama.2016.5148
- Schäfer, G., Kreuels, B., Schmiedel, S., Hertling, S., Hüfner, A., Degen, O., Lunzen, J. V., & Wiesch, J. S. Z. (2016). High proportion of HIV late presenters at an academic tertiary care center in northern Germany confirms the results of several cohorts in Germany: Time to put better HIV screening efforts on the national agenda? Infection, 44(3), 347–352. https://doi.org/https://doi.org/10.1007/s15010-016-0880-4
- Schupp, J., & Gerlitz, J. (2014). Big Five Inventory-SOEP (BFI-S) [Internet]. https://doi.org/https://doi.org/10.6102/zis54
- Valbert, F., Wolf, E., Schewe, C. K., Klauke, S., Hanhoff, N., Hoffmann, C., Preis, S., Pahmeier, K., Wasem, J., & Neumann, A. (2020). ). Cost of human immunodeficiency virus (HIV) and determinants of healthcare Costs in HIV-infected treatment-Naive patients initiated on antiretroviral therapy in Germany: Experiences of the PROPHET study. Value in Health, 23(10), 1324–1331. https://doi.org/https://doi.org/10.1016/j.jval.2020.04.1836
- A Working Group of the Office of AIDS Research Advisory Council (OARAC). (2017). Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. https://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL003510.pdf
- Zoufaly, A., Heiden, M. A. D., Marcus, U., Hoffmann, C., Stellbrink, H., Voss, L., Lunzen, J. V., & Hamouda, O. (2011). Late presentation for HIV diagnosis and care in Germany. HIV Medicine, 13(3), 172–181. https://doi.org/https://doi.org/10.1111/j.1468-1293.2011.00958.x